Bowhead Sets November 13 Vote on $34/Share American Family Buyout
BOW sits 61% above its 52-week low of $21.21.
Summary
Bowhead Specialty's definitive proxy sets a November 13, 2026 shareholder vote on the $34 per share all-cash acquisition by American Family, with total deal value of approximately $1.12 billion.
Key Events · M&A and Partnerships · BOW
-
Special Meeting Set for November 13
Shareholders of record as of October 12, 2026 will vote on the merger agreement at a virtual special meeting on November 13, 2026. Approval requires a majority of all outstanding shares and a majority of shares held by Subject Stockholders.
-
Merger Consideration of $34 Per Share
Each outstanding share will be converted into the right to receive $34.00 in cash, representing a total deal value of approximately $1.12 billion based on 32,945,158 shares outstanding.
-
Golden Parachute Compensation Disclosed
CEO Stephen Sills' total merger-related compensation is estimated at $32,390,388, including $18.9 million in equity awards, $10.5 million in cash, and a $3 million tax gross-up. CFO Brad Mulcahey and Chief Underwriting Officer David Newman have packages of $2.8 million and $4.7 million respectively.
-
Regulatory Approvals Progressing
The HSR waiting period expired on September 28, 2026, and the Texas Department of Insurance issued a non-objection letter on September 15, 2026. Wisconsin regulatory approval remains pending.
Analysis · BOW · Finance
The definitive proxy statement finalizes the shareholder vote on the $1.2 billion all-cash acquisition by American Family. The special meeting is set for November 13, 2026, with a record date of October 12, 2026. The filing also discloses golden parachute compensation for named executive officers, including CEO Stephen Sills' total package of $32.4 million, and a $35 million termination fee. With 32.9 million shares outstanding and the merger consideration at $34 per share, the total deal value is approximately $1.12 billion. The transaction remains subject to shareholder approval and regulatory conditions, though the HSR waiting period expired on September 28, 2026 and Texas regulatory approval was received on September 15, 2026.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 31% of the 1656 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.01%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BOW was trading at $34.13 on NYSE in the Finance sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $21.21 to $35.07. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.